Paul Tudor Jones’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Paul Tudor Jones’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-65	Closed	-$1.37K	–	2904
2024 Q1	$1.37K	Buy	+65	New	+$1.45K	﹤0.01%	2142
2021 Q2	–	Sell	-13,782	Closed	-$380K	–	2017
2021 Q1	$380K	Buy	+13,782	New	+$412K	0.01%	1225
2020 Q4	–	Sell	-24,422	Closed	-$586K	–	1689
2020 Q3	$586K	Sell	24,422 -10,730	-31%	-$250K	0.03%	752
2020 Q2	$816K	Buy	+35,152	New	+$696K	0.04%	543

Other funds holding CALT

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $289M AUM 60.38% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $780M AUM 24.84% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMC

Planning Capital Management Corporation Paoli, Pennsylvania $151M AUM 30.62% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paul Tudor Jones's CALT Position: Q2 2024 in Review

Paul Tudor Jones sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2024, closing a stake of 65 shares — an estimated $1.37K sold.

Paul Tudor Jones first reported a position in CALT in Q2 2020 and held it in 4 quarters. The position peaked at $816K in Q2 2020. 18 funds tracked by Wall St. Rank hold CALT as of Q2 2024.

Paul Tudor Jones reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2024 after selling out during the quarter.
Paul Tudor Jones sold 65 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2024, an estimated $1.37K.
Paul Tudor Jones first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2020 and held it in 4 quarters.
Paul Tudor Jones's Calliditas Therapeutics AB American Depositary Shares position peaked at $816K in Q2 2020.
18 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.